By Kym McNicholas
We started our most recent PAD Leg Saver Hotline with a trip down memory lane. Black-and-white TVs, foil-wrapped antennas, three whole channels if you were lucky, and the day the whole world stopped for the moon landing. In our community, nostalgia is often the only escape from a brutal present.
It didn’t take long before the conversation shifted from 1970s Firebirds to something far more terrifying: what happens when the medical devices meant to save your life actually fail you?
One of our warriors, Marie, shared a discovery that should stop every PAD patient in their tracks. After a series of complications, doctors went back in and found she was missing a three-to-four-inch section of her artery.
“They found a stent there that had corroded and ate my artery. The only thing that saved my ass is literally because of all the blood clots I get... otherwise I would have had internal bleed and I would have been dead before they knew it.”
This is exactly why I tell every patient: keep your device cards. You need to know the brand, manufacturer, and model of every stent or graft in your body. If something goes wrong, you shouldn’t just become a line item in a manufacturer’s adverse event database. You need to be an empowered advocate who can walk into any emergency room and tell them exactly what’s inside you. You can also report device problems directly to the FDA as a patient. That option exists and not enough people know about it.
Is It Bone Pain or Is It PAD?
We hear this constantly on the hotline: “It feels like the pain is in my bone.” If you have PAD, you know that sledgehammer sensation deep in your ankle or foot.
Here’s the thing though: it’s not actually your bone that’s hurting.
“It’s in the muscle around the bones. Lack of blood flow to the muscles... makes it feel like it’s actually bone pain.”
When your muscles are starved of oxygen, they scream. Ischemic muscle pain from poor circulation is frequently mistaken for orthopedic or bone pain, which is why so many PAD patients spend years chasing X-rays and orthopedic consults before anyone thinks to check their circulation. Understanding that this is a vascular problem, not a skeletal one, is the difference between a useless imaging scan and a life-saving vascular workup.
The Drug Interaction Your Doctor May Not Have Mentioned
We also dug into a topic that doesn’t get enough attention in the exam room: the interaction between clopidogrel (Plavix) and high-dose atorvastatin. There’s published research from Dr. Anahita Dua and colleagues at Massachusetts General Hospital/Harvard Medical School examining exactly this issue in PAD patients.
Both drugs compete for the same liver enzyme pathway, CYP3A4, which is how the body activates and processes them. Clopidogrel is a prodrug that actually requires CYP3A4 to become active in your system. When high-dose atorvastatin is on board, it competes for that same pathway and can reduce how much active clopidogrel actually gets delivered.
Think of it as the school bus analogy we use on the hotline:
“It’s like the big bully on the school bus and it doesn’t let the clopidogrel or Plavix onto the school bus. So it’s just not being delivered.”
The research shows this effect is dose-dependent, meaning it gets more pronounced at higher statin doses. If you’re on 80mg of atorvastatin and your stents keep clogging, it’s a legitimate question to raise with your doctor. Ask whether a statin that doesn’t go through the CYP3A4 pathway, like pravastatin or rosuvastatin, might be worth considering for your specific situation. This isn’t an argument against statins altogether; they absolutely have their place in vascular disease management. It’s about making sure the antiplatelet therapy you’re taking is actually doing its job.
Hope on the Horizon: Bioengineered Vessels
Despite the “no landing zones” and the failed bypasses, we ended with real reason for hope. We talked about Humacyte, a Durham-based biotech company working on what they call an Acellular Tissue Engineered Vessel (ATEV). In December 2024, their product SYMVESS received full FDA approval for vascular trauma repair in patients where their own vein isn’t usable. For PAD specifically, the ATEV has received FDA Regenerative Medicine Advanced Therapy (RMAT) designation and is currently in late-stage clinical trials. That designation is significant because it opens pathways for expedited FDA review down the road.
This is exactly the kind of innovation that could change the game for patients stuck in the cycle of repeated interventions with nowhere left to graft.
My message to you: don’t just act like a patient. Act like a partner in your care.
How to Take Action
If you’re tired of being bent over in pain or dismissed by your care team, reach out.
Call the Leg Saver Hotline: 1-833-PAD-LEGS (723-5347)
Join the Community: Find us on Facebook at the Peripheral Artery Disease (PAD) Official Group: PADsupportgroup.org
Resources: Visit PADhelp.org for more information on saving your limbs.
Relapsing or failing a procedure isn’t the end. It’s a reason to dig harder into the why. Let’s get there together.
Peripheral Artery Disease, stent failure symptoms, claudication pain, Plavix and atorvastatin interaction, CYP3A4 clopidogrel, Humacyte SYMVESS PAD trials, vascular health advocacy, Kym McNicholas, Leg Saver Hotline